MBI Seminar

  1. Events
  2. MBI Seminar

Views Navigation

Event Views Navigation

Today

CD74, invariant chain, a modulator of endosomal maturation and potential cancer immunotherapy vaccine by Prof Oddmund Bakke, University of Oslo

MBI Seminar Room Lvl 5 T-Lab, Level 5, 5A Engineering Drive 1, Mechanobiology Institute

MBI Weekly Meeting Seminar Time: 9.30am – 10.30am Date: Friday, 8 December 2017 Venue: Level 5 Seminar Room, T-Lab CD74, invariant chain, a modulator of endosomal maturation and potential cancer immunotherapy vaccine by Prof. Oddmund Bakke from University of Oslo  

Have an event you’d like to list here? Contact here.

MBI

Decoding the living machine

At the Mechanobiology Institute, National University of Singapore, our goal is to develop the world’s leading centre for mechanobiology research and education. Our research aims to interrogate biological systems from a physical and mechanical perspective at the molecular, cellular, and tissue level, with the eventual goal to leverage basic science discoveries in mechanobiology into biomedical innovations.

MBI gratefully acknowledges support from:

National University of Singapore

National Research Foundation Singapore

Ministry of Education Singapore

Contact us

Mechanobiology Institute (MBI)

National University of Singapore
    T-Lab, #10-01
    5A Engineering Drive 1
    Singapore 117411

Campus map

  mbi.nus.edu.sg
  mbi@nus.edu.sg
  +65 6601 5424

Toggle Sliding Bar Area

About the National University of Singapore

About NUSA leading global university centred in Asia, NUS is Singapore's flagship university, offering a global approach to education and research with a focus on Asian perspectives and expertise.

About the Mechanobiology Institute, National University of Singapore

About MBIOne of four Research Centres of Excellence at NUS, MBI is working to identify, measure and describe how the forces for motility and morphogenesis are expressed at the molecular, cellular and tissue level.
Privacy Notice
This site uses cookies. By clicking accept or continuing to use this site, you agree to our use of cookies. For more details, please see our Privacy Policy. Accept
Go to Top